Related content

Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 14, Iss. 12, 2017-10 ,pp. : 1305-1317

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of Pervasive Developmental Disorder in Down’s Syndrome

By Lowenthal Rosane   Paula Cristiane   Schwartzman Jose   Brunoni Décio   Mercadante Marcos  

Journal of Autism and Developmental Disorders, Vol. 37, Iss. 7, 2007-08 ,pp. : 1394-1395

Springer Publishing Company

Access to resources Recommend Favorite

Down’’s syndrome and Alzheimer’’s disease: two sides of the same coin

By Potter Huntington  

Future Neurology, Vol. 3, Iss. 1, 2008-01 ,pp. : 29-37

Future Medicine

Access to resources Recommend Favorite

Plasma amino acids and neopterin in healthy persons with Down’s syndrome

By Coppus A. W.   Fekkes D.   Verhoeven W. M. A.   Tuinier S.   Egger J. I. M.   van Duijn C. M.  

Journal of Neural Transmission, Vol. 114, Iss. 8, 2007-08 ,pp. : 1041-1045

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent cerebral embolism in a young adult with Down’s syndrome: A case report

By Ishida Shimon   Date Masamichi   Doi Yoshimitsu   Sato Toshihiko   Sugino Masakazu   Kimura Fumiharu   Hanafusa Toshiaki  

Journal of Neurology, Vol. 251, Iss. 10, 2004-10 ,pp. : 1275-1277

Springer Publishing Company

Access to resources Recommend Favorite